Dynavax shares surged nearly 40% in premarket trading after Sanofi agreed to acquire the company for $2.2 billion in cash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback